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Abstract
Marburg virus (Marburg marburgvirus; MARV) causes sporadic outbreaks of Marburg 
hemorrhagic fever (MHF) in Africa. The Egyptian fruit bat (Rousettus aegyptiacus) has been 
identified as a natural reservoir based most-recently on the repeated isolation of MARV directly 
from bats caught at two locations in southwestern Uganda where miners and tourists separately 
contracted MHF from 2007–08. Despite learning much about the ecology of MARV through 
extensive field investigations, there remained unanswered questions such as determining the 
primary routes of virus shedding and the severity of disease, if any, caused by MARV in infected 
bats. To answer these questions and others, we experimentally infected captive-bred R. 
aegyptiacus with MARV under high (biosafety level 4) containment. These experiments have 
shown infection profiles consistent with R. aegyptiacus being a bona fide natural reservoir host for 
MARV and demonstrated routes of viral shedding capable of infecting humans and other animals.
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INTRODUCTION
Marburg hemorrhagic fever is a severe and often fatal disease in humans caused by infection 
with Marburg virus (family Filoviridae, Marburg marburgvirus; MARV). Human-to-human 
transmission of MARV occurs primarily through contact with infected body fluids, similar 
to that for several members of the genus Ebolavirus (family Filoviridae): Zaire ebolavirus 
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(Ebola virus), Sudan ebolavirus (Sudan virus), and Bundibugyo ebolavirus (Bundibugyo 
virus). The first documented MARV infection in humans occurred in laboratory workers in 
Germany and Yugoslavia in 1967, when MARV-infected green monkeys (Cercopithecidae: 
formerly Cercopithecus aethiops; currently Chlorocebus tantalus; Wilson and Reeder 2005) 
were imported from Uganda (Siegert et al. 1968) and used for vaccine development. Since 
that time, 10 additional outbreaks have occurred, most in eastern sub-Saharan Africa. Two of 
these outbreaks, one in Durba, Democratic Republic of the Congo and another in Uige, 
Angola, had over 150 cases with >80% case fatality (Bausch et al. 2006; Towner et al. 
2006). The Durba outbreak lasted for 2 yr, (1998–2000) and was epidemiologically linked to 
subterranean gold mining (Bausch et al. 2006). The mine contained large numbers of a 
common cave-dwelling fruit bat, Rousettus aegyptiacus (Egyptian fruit bat; EFB), that has 
been subsequently identified as a natural reservoir for MARV. This discovery was based on 
finding MARV-specific RNA and IgG antibodies (Swanepoel et al. 2007; Towner et al. 
2007) and the presence of infectious virus (Towner et al. 2009; Amman et al. 2012) in wild 
EFB, including those inhabiting gold mines and tourist attractions in Uganda where more-
recent MARV outbreaks have occurred. Moreover, longitudinal studies have shown that 
periods of spillover to humans may be associated with seasonal pulses of active MARV 
infections in juvenile EFB during annual reproductive cycles (Amman et al. 2012).
Many basic aspects of MARV ecology are not well known, including MARV replication 
kinetics and dissemination in bat tissues and the mechanism(s) by which the virus is 
transmitted from bats to other bats or to humans. Two experimental infection studies 
involving filoviruses in captive bats have been informative. The first study utilized a variety 
of plants and animals, including three species of bats (Mops condylurus [Angolan free-tailed 
bat], Chaerephon pumila [little free-tailed bat], and Epomophorus wahlbergi [Wahlberg’s 
epauletted fruit bat]) that were either exposed to or injected with Ebola virus (Swanepoel et 
al. 1996). Ebola virus replicated only in bats and could be detected for up to 3 wk in feces. 
In a second study, a high-passage (P38) Vero cell-adapted MARV strain (Hogan) was used to 
infect EFB (Paweska et al. 2012). Virus was injected subcutaneously and intraperitoneally 
into adult and newborn bats from mixed gender groups. Marburg virus replicated in EFB 
without obvious disease, consistent with expectations for MARV replication in its reservoir 
host. However, virus shedding could not be detected in oral secretions, feces, or urine.
Here, we report a serial euthanasia study in which low-passage (P2) MARV, isolated from a 
naturally infected EFB, was used to infect first generation, age-and gender-matched, captive-
bred EFB. We determined the infection kinetics in 15 major tissues including blood from 
days 3–28 postinfection (PI), and we isolated virus multiple times from oral secretions of 
infected bats. Further, we show that MARV can be detected for up to 6 consecutive days in 




All experimental procedures were conducted with approval from the Centers for Disease 
Control and Prevention (CDC, Atlanta, Georgia, USA) Institutional Animal Care and Use 
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Committee, and in strict accordance with the Guide for the Care and Use of Laboratory 
Animals (Committee for the Update of the Guide for the Care and Use of Laboratory 
Animals 2011). The CDC is an Association for Assessment and Accreditation of Laboratory 
Animal Care International fully accredited research facility. No human patient-derived 
clinical materials were used in these studies.
Procedures conducted with infectious MARV or with infected bats were performed at the 
CDC under biosafety level 4 (BSL-4) laboratory conditions in accordance with Select Agent 
regulations (Animal and Plant Health Inspection Service and Centers for Disease Control 
and Prevention 2014). All investigators and animal handlers followed strict BSL-4 biosafety 
and infection control practices (CDC 2009b) to prevent cross-contamination between 
experimentally infected and control bats.
All bats used in this study were first-generation, captive-born bats from an MARV-free 
breeding colony founded from wild-caught EFB imported from Uganda. The experimental 
group consisted of 30 juvenile males, 4–5 mo old, with an average weight of 107 g. The bats 
were housed in groups of ≤9 in designated experimental and control caging (interior 
dimensions 61×71×76 cm long, wide, and high, respectively) in a climate-controlled BSL-4 
laboratory animal room with a 12 h day:night cycle. Cross-contamination between 
experimental and control bats was prevented by housing within separate isolation units 
(Duo-Flow Mobile Units, Lab Products Inc., Seaford, Delaware, USA) with high efficiency 
particulate air-filtered inlet and exhaust air supply. Daily food consisted of chopped bananas, 
watermelon, cantaloupe, seedless grapes, apples, and pears dusted with a protein vitamin 
supplement (Lubee Bat Conservancy, Gainesville, Florida, USA).
Virus stock
An MARV isolate (371bat virus; second passage on Vero-E6 cells), obtained from a 
naturally infected EFB (371bat) collected during an MARV outbreak ecologic investigation 
in southwestern Uganda (Towner et al. 2009), was diluted in a solution of Dulbecco’s 
modified Eagle’s medium (DMEM) to a concentration of 1×104 tissue culture infective dose 
50 (TCID50)/mL.
Experimental design
The bats were randomly divided into three groups (A–C), each consisting of nine virus-
inoculated bats and one control bat. Baseline blood samples, body weights, and temperatures 
were taken prior to inoculation. For inoculations, all bats were anesthetized with isoflurane 
and subcutaneously injected in the mid-ventral abdomen with either 250 μL of MARV 
prepared in DMEM for a total dose of 104 TCID50 per bat (n=27), or 250 μL of sterile 
DMEM for control bats (n=3). Rectal temperatures and body weights were recorded daily. 
Oral and rectal samples were collected daily for subsequent virus titration. Blood samples 
were taken from each bat on alternate days. On days 3, 5, 6, 7, 8, 9, 10, 12, and 28 PI, one 
bat from each group (A–C, n=3 per time point) was euthanized under anesthesia via cardiac 
exsanguination and full postmortem necropsies were performed. The three negative control 
bats were euthanized and similarly processed on day 28 PI. Cardiac blood was taken upon 
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euthanasia for later analysis. Complete tissue sets (see below) were taken and either stored 
in RNA extraction buffer for PCR analysis or frozen and stored under liquid nitrogen vapor.
Postinfection procedures
Beginning on day 1 PI, body weights and temperatures of all animals were recorded. A 
temperature probe covered with a plastic sheath (MABIS Healthcare, Waukegan, Illinois, 
USA) was used to measure the rectal temperature of each bat. The plastic sheath was then 
cut and placed into a deep-well plate with 500 μL of MagMax lysis buffer solution (Life 
Technologies, Grand Island, New York, USA) for PCR analysis. Two polyester-tipped 
applicators (Fisher Scientific, Grand Island, New York, USA) were used to swab the inside 
of each bat’s mouth. The swabs were immediately placed in either a deep-well plate with 
500 μL of lysis binding solution for PCR analysis or in viral transport medium for isolation. 
Blood samples (≤60 μL) were taken via venipuncture from the cephalic vein on the 
propatagium every-other day on days 1–14 and then on days 21 and 28. Necropsies were 
performed on the aforementioned euthanasia days to collect skin, liver, spleen, large 
intestine (colon-rectum), small intestine, mesenteric lymph node, kidney, adrenal gland, 
heart, lung, salivary gland, testis, urinary bladder, and brain.
Sample testing and RNA extraction
All tissue, blood, and swab samples were analyzed with quantitative reverse transcriptase 
PCR (qRT-PCR) targeting VP40 and using reagents and procedures described by Amman et 
al. (2012). For tissue specimens, approximately 100 mg were placed in 2-mL grinding vials 
(OPS Diagnostics, Lebanon, New Jersey, USA) with 1 mL of MagMax lysis buffer 
concentrate and homogenized as described by Amman et al. (2012). Specimen sizes of some 
tissues (urinary bladder, adrenal gland, and testis) were under 100 mg due to availability but 
remained consistent within a tissue type. Total RNA extraction was achieved using the 
MagMax-96 Total RNA Isolation kit (Life Technologies) per manufacturer’s 
recommendations and the AM1830_DW protocol preloaded on the MagMax Express-96 
Deep Well Magnetic Particle Processor. Each reaction used 125 μL of the tissue lysate with 
75 μL of 100% isopropanol. To account for sample-to-sample variation, qRT-PCR results for 
tissues were normalized to results for 18s rRNA using a commercially available eukaryotic 
18S rRNA primer-probe assay (Applied Biosystems, Grand Island, New York, USA) 
according to manufacturer’s instructions. Gamma-irradiated Rift Valley fever virus (RVFV; 
0.25 μL per sample) was added to the lysis buffer solutions as an extraction control for blood 
and swab samples. The RVFV qRT-PCR was performed as described by Bird et al. (2007) 
but using 58 C for the annealing temperature, as for MARV.
Blood samples (20 μL; whole, nonheparinized) were added to 130 μL of lysis binding 
solution (1:1 ratio of lysis buffer concentrate and 100% isopropanol) and extracted using the 
MagMax-96 Viral RNA Isolation kit and the AM1836_DW_50v2 protocol preloaded on the 
MagMax Express-96 Deep Well Magnetic Particle Processor.
Polyester-tipped applicators used as oral swabs and the plastic probe cover sheaths used for 
rectal swabs were placed into wells of a deep-well plate containing 500 μL of lysis binding 
solution. Viral RNA was extracted using the 5× MagMax Pathogen RNA/DNA kit per 
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manufacturer’s instructions, using 200 μL of sample and 500 μL of lysis binding solution, 
and the 4462359_DW_HV protocol preloaded on the MagMax Express-96 Deep Well 
Magnetic Particle Processor.
Standard curves for qRT-PCR results were generated by serial, 10-fold dilutions of 371bat 
MARV stock virus of known titer (TCID50/mL) in DMEM and added to blood, tissue (calf 
liver) homogenate, or DMEM in the same proportions and methods as that used for 
collecting blood, tissues, or swab samples from bats. The relative TCID50/mL (fluid 
samples) or TCID50/g (tissue samples) equivalents were interpolated from the relevant 
standard curve. The standard curve for swab samples was based on a calculation in which 20 
μL of virus solution was absorbed by the swab applicator.
Virus isolation
Polyester-tipped applicators used for oral swabs were placed into 500 μL DMEM-fungizone-
penstrep (100 units/mL penicillin; 100 μg/mL streptomycin; 2.50 μg/mL amphotericin B; 
Life Technologies) with 2% fetal calf serum and then flash frozen in liquid nitrogen until 
virus isolations were attempted. The entire eluate was used to inoculate Vero-E6 cells in 25-
cm2 flasks for 1 h at 37 C and 5% CO2. DMEM-fungizone-penstrep containing 2% fetal calf 
serum was then added and cultures were monitored for 14 days with a media change on day 
7. All cultures were tested by immunofluorescent assays for MARV.
Serology
Blood samples taken for serologic analysis were tested by enzyme-linked immunosorbent 
assay (ELISA) for IgG antibodies reactive to MARV, exactly as described in Ksiazek et al. 
(1999a, b) with the modification that 96-well plates were coated with 50 ng/well of 
recombinant MARV nucleocapsid protein (NP; Angola strain) expressed in Escherichia coli 
and the sum optical density (OD) values adjusted by subtracting reactivity at each 4-fold 
dilution (1:100 to 1:6,400) to Reston ebolavirus NP protein similarly expressed and purified 
from E. coli.
RESULTS
Evidence of infection was found in all 27 bats inoculated subcutaneously with MARV. No 
disease-related mortality or overt signs of morbidity were observed in any of the animals. 
The bats were monitored daily and maintained normal feeding routines. No significant 
differences in percentage weight change were found throughout the course of the infections 
between the experimentally infected bats and the control bats or among experimental groups 
(F3,26=0.58; P>0.10; data not shown). Average body temperatures for experimental groups 
were within normal ranges and were consistent with those observed in the control groups 
(data not shown).
Viral loads (Table 1), measured by qRT-PCR analysis of viral RNA, are hereafter reported as 
mean TCID50 equivalents per gram of tissue or milliliter of fluid. Viremia (Fig. 1) was 
detected in all but three (bats 40002, 42509, and 42336) of the 27 bats infected with MARV 
as early as day 1 PI. Mean viral load values peaked on day 5 PI (mean value: 2.23×103 
TCID50/mL; single bat: 7.79×103 TCID50/mL) and were cleared from the blood by day 10 
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PI. The largest number of bats viremic at one time was 20 on day 4 PI. The average time 
span of detectable viremia for all bats was short, 3 days, and ranged from 1–9 days.
The ELISA results show anti-MARV IgG levels, represented by adjusted sum OD values 
(Fig. 2) approaching a sum OD positive cut-off value of 0.95 by day 9 PI. All bats 
euthanized after day 10 PI seroconverted with sum ODs ranging from 2.56–4.97 with titers 
≥400.
Signs of disseminated infection in tissues, detectable by increases in mean viral loads 
relative to blood, occurred in the spleen and liver (Fig. 3). Infection was first detected in 
liver on day 3 PI, the first scheduled day of euthanasia, and mean viral loads peaked on day 
6 (5.41×104 TCID50/g). Infection in the spleen was also detected on day 3 and peaked on 
day 5 (3.18×105 TCID50/g). Mean viral loads decreased dramatically in both of these tissues 
by 10–12 days PI and were cleared (liver) or only weakly positive (spleen; 5.04×101 
TCID50/g) by day 28. Mean viral loads in skin samples taken from the inoculation site 
showed the highest viral loads of all tissues (Fig. 3). Infection in the skin was detected on 
day 3, peaked on day 7 (1.26×106 TCID50/g), and was cleared by day 12. Spleen, liver, 
blood, and skin at the inoculation site were the most-frequently qRT-PCR–positive samples 
from infected bats, although virus was detected in 14 additional tissue types (Table 1). Of 
note, infection in bat 42853 was widespread on day 8 PI with detectable virus present in all 
but one tissue type. Most organs compatible with virus shedding, e.g., kidney, salivary gland, 
bladder, and large intestine (Figs. 3, 4), also showed signs of infection as early as day 3, but 
with lower viral loads, and peaked at later times than did liver, spleen, or skin. The quantity 
of MARV in the kidney did not peak until day 7 (3.02×103 TCID50/mg), but persisted 
through day 12 and was cleared by day 28, while those for salivary gland and large intestine 
peaked on day 8 (4.34×102 TCID50/g and 5.17×102 TCID50/g, respectively) and were 
cleared by day 12. In the bladder, mean viral loads peaked on day 5 (4.31×101 TCID50/g) 
and were cleared by day 9. Viral loads detected in the inoculation-site skin, liver, and spleen 
samples were all much higher than those detected in corresponding blood samples taken at 
the same time, as well as the 104 TCID50 inoculum dose, indicating true viral replication in 
these tissues.
Marburg virus-positive oral swabs were obtained on day 4–14 PI (n=17). The highest viral 
loads were detected on day 8 (1.16×104 TCID50/mL) and cleared from oral secretions by 
day 14 (Fig. 5). Three virus isolates were obtained from oral swabs from three infected bats, 
two bats (36089, 42030) on day 8, and one bat (85963) on day 11. Marburg virus RNA was 
also detected in rectal swabs (n=6, Fig. 5) from days 4–11 PI, albeit with much less 
frequency than in oral swabs and at much lower levels than that found in blood taken from 
the same animals on the same day, indicating that blood contamination of the rectal swabs 
cannot be ruled out.
DISCUSSION
Our results show that R. aegyptiacus can become infected with MARV through experimental 
subcutaneous inoculation and without mortality or any indication of explicit morbidity. Our 
experimental approach differs significantly from an MARV study described by Paweska et 
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al. (2012). The bats we used were one generation removed from the wild-caught colony 
founder bats and had not experienced multiple generations of colony inbreeding. 
Additionally, our bats were 5-mo-old juveniles which are the approximate age-cohort most 
frequently infected by MARV in the wild (Amman et al. 2012). Further, we used a low-
passage, bat-borne virus (371bat MARV; Towner et al. 2009), thus minimizing the potential 
for confounding effects of adaptive mutations accumulated through passage in cell culture or 
humans. Finally, all bats in this study were uniformly inoculated by a single subcutaneous 
injection route, with representative daily tissue samples taken through the acute phase of the 
infection, days 5–10 PI, and additionally sampled on days 3, 12, and 28. Oral and rectal 
swabbing was performed on a rigorous schedule, daily from days 1–12 PI and on days 14, 
21, and 28.
All 27 bats inoculated with MARV became infected, and all but three underwent a viremic 
stage. Many bats were viremic for 1 day only (n=6), and it is likely that the days on which 
some bats (40002 and 42509) were viremic were missed due to the alternate-day bleeding 
schedule. These two bats seroconverted on days 10 and 12, respectively, while the third 
nonviremic bat (42336) was euthanized on day 3 and had MARV-positive (by qRT-PCR) 
liver, spleen, salivary gland, and skin at the inoculation site (Table 1). Detectable viremia in 
naturally infected bats was found in only four of 71 (6%) that were positive for virus RNA in 
pooled liver-spleen samples (Towner et al. 2009; Amman et al. 2012).
Viral RNA levels (by qRT-PCR) in visceral tissues indicate that liver and spleen have the 
highest viral loads and are the first and most-frequent sites of disseminated viral replication. 
These data are consistent with those from naturally infected bats caught at MARV outbreak 
locations in Uganda (Towner et al. 2009; Amman et al. 2012). Mean viral loads in tissues 
from experimentally infected bats were considerably higher (liver, day 5: 5.41×104 
TCID50/mg; spleen, day 5: 3.18×105 TCID50/mg) than those found in the blood (day 5: 
2.23×103 TCID50/mL), ruling out residual virus in blood as a major contributor to the qRT-
PCR signal. Peak viral loads in kidneys were also higher than that in blood (day 7: 3.02×103 
TCID50/mg) and also peaked later than in liver and spleen. Finding MARV in salivary gland, 
kidney, bladder, and large intestine are significant because these organs represent potential 
avenues of virus shedding. Also, viral loads in these four tissues peaked as the loads in blood 
were declining. Visceral tissues positive for MARV by qRT-PCR were not found in bats 
40002, 42509, and 85963 but, as mentioned previously, bats 40002 and 42509 seroconverted 
on days 10 and 12, respectively, and bat 85963 was viremic on day 5 and seroconverted by 
day 28. These three bats (40002, 42509, 85963) were euthanized in the later days of the 
experiment (day 10, 12, and 28, respectively) when viral loads were waning or were 
completely cleared from visceral tissues of other bats. The number of qRT-PCR–positive 
tissues found in one bat (428530) indicates the potential for widespread infection during the 
acute phase of virus replication, a finding also observed in wild-caught MARV-infected bats 
(Amman et al. 2012). Despite widespread virus dissemination, we observed no significant 
changes in daily food consumption, body weight, or daily body temperature, and no signs of 
overt morbidity or behavioral changes such as waning appetite, overly aggressive behavior, 
separation from cage mates, lethargy, or reduced or abandoned grooming.
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A key outcome in this study was the detection of MARV-positive oral and rectal swabs. 
Importantly, infectious MARV was isolated from the oral cavities (oral swabs) of bats with 
103 TCID50/mL equivalent or greater viral loads (Fig. 5). Unfortunately, urine samples were 
difficult to collect because bats tended to urinate during the capture process. These findings 
demonstrate MARV shedding in a filovirus natural reservoir species and have implications 
for virus transmission to human and nonhuman primates and perhaps other bats. Fruit bats 
are known for test-biting fruit and generating large amounts of masticated fruit spats under 
the trees in which they feed (Jacobsen and Du Plessis 1976). Spats and half-eaten fruit with 
residual MARV could be readily consumed by susceptible animals. We speculate that a 
major route of horizontal bat-to-bat MARV transmission is through biting, based on the 
success of the subcutaneous inoculation route and the reported inability of EFB to be 
infected by an oronasal route (Paweska et al. 2012). However, a mucosal route of infection 
in bats cannot be completely discounted because the bats receiving oronasal inoculation in 
that study were only monitored for 21 days, and oronasal inoculation with a nonculture-
adapted, bat-borne MARV has not been attempted. Egyptian fruit bats occupy extremely 
close quarters with their roost mates (Fig. 6) and altercations are common (Kingdon 1974; 
Jacobsen and Du Plessis 1976; Kwiecinski and Griffiths 1999; Amman et al. 2012). 
Moreover, sexual interactions are typically preceded by males biting unwilling females, 
followed by continual muzzle licking during copulation (Kingdon 1974). Transmission of 
other zoonotic viruses through biting has been reported (Rupprecht et al. 2002; Calisher et 
al. 2007).
The viral loads found in rectal swabs were low but may still represent a potential avenue for 
viral shedding and bat-to-human (or nonhuman primate) or bat-to-bat transmission. In 
Python Cave, Uganda, the most actively infected group of bats (older juveniles; Amman et 
al. 2012) tend to occupy a variety of spaces at lower levels along the cave walls and floor, 
where deposits of fresh guano and urine are distributed continually. The excretory route may 
be a mechanism of MARV transmission between bats and primates and would not require 
any physical contact (bites, butchering for consumption, etc.). When the bats are disturbed 
by human entry into their roost, they typically excrete bodily wastes on takeoff or soon after 
taking flight (B.R.A., J.S.T., pers. obs.), dropping potentially infectious bodily waste that, 
without appropriate personal protective equipment, could come into contact with exposed 
skin and mucous membranes. Tourists infected with MARV at Python Cave reported not 
having any direct contact with the bats (CDC 2009a; Timen et al. 2009).
Our experimental infections shed new light on the virus-host interactions between EFB and 
MARV. First and foremost, these experimental infections provide strong evidence of viral 
shedding through oral secretions, indicating a viable route for horizontal transmission. Our 
data also point to a potential secondary route of infection among bats through a rectal 
excretory route, which may also be a route of infection from bats to humans. Regardless of 
the exact mechanisms, this study confirms that exposure to MARV-contaminated bat fluids 
(saliva and feces) should be avoided. Public health authorities should continue to discourage 
people from entering EFB roosting sites (caves and mines) for any reason or from harvesting 
these bats for food.
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Viral RNA in blood of Egyptian fruit bats (Rousettus aegyptiacus) inoculated in the 
laboratory with Marburg virus. Viral RNA levels in blood (log10 tissue culture infective dose 
50 [TCID50]/mL equivalent) days postinfection for each bat (n=27) are shown for three 
groups of bats.
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Serology results for Egyptian fruit bats (Rousettus aegyptiacus) inoculated with Marburg 
virus. Results for anti-Marburg virus IgG measured by enzyme-linked immunosorbent assay 
are shown as adjusted sum optical densities (OD) by day postinoculation for all infected bats 
(n=27) at the time of euthanasia for each group.
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Marburg virus RNA in skin, liver, spleen, and kidneys of Marburg virus-infected Egyptian 
fruit bats (Rousettus aegyptiacus). Mean viral RNA levels measured by quantitative reverse-
transcriptase–PCR in skin at inoculation site (IS), liver, spleen, and kidneys (n=3; log10 
TCID50/g equivalent) at the time of euthanasia (days). Each symbol (point) represents the 
mean viral load detected in that tissue in the three bats euthanized on that day. For reference, 
the mean viral loads detected in blood from those same bats on that day are shown (dashed 
black-yellow line). TCID=tissue culture infective dose.
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Marburg virus RNA in salivary gland, bladder, and large intestine of Egyptian fruit bats 
(Rousettus aegyptiacus) inoculated with Marburg virus. Mean viral RNA levels were 
measured by quantitative reverse transcriptase PCR (log10 TCID50/g equivalent) at the time 
of euthanasia (days). Each symbol (point) represents the mean viral load detected in that 
tissue in the three bats euthanized on that day. For reference, the mean viral loads detected in 
blood from those same bats on that day are shown (dashed black-yellow line). TCID=tissue 
culture infective dose.
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Marburg virus RNA in oral and rectal swabs from Egyptian fruit bats (Rousettus 
aegyptiacus) inoculated with Marburg virus. Viral levels from oral (square) and rectal 
(circle) swabs by day postinfection. Swab viral level values (log10 TCID50/mL equivalent) 
are equivalents of a stock tested (see Materials and Methods), not the actual amount of virus 
in saliva or feces, because the volume of absorbed oral secretion could not be calculated. 
Oral swabs from which Marburg virus could be isolated are depicted by an asterisks on days 
8 (n=2) and 11 (n=1). The average viremia (Ave viremia swab pos) over time for bats with 
positive swabs (oral or rectal) is shown. TCID=tissue culture infective dose.
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A large, densely populated colony of Egyptian fruit bats (Rousettus aegyptiacus) at Python 
Cave in Queen Elizabeth National Park, Uganda is shown. The large number of bats and 
their affinity for close contact is thought to perpetuate the circulation of Marburg virus 
infection within the colony. Marburg virus has been found in this population during every 
sampling effort (Amman et al. 2012).
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